Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2024

The contribution of digital technology and AI in early phase trials

AI in early phase trials: Can implementation of AI improve our trials?

Date

27 Feb 2024

Session

The contribution of digital technology and AI in early phase trials

Topics

Statistics

Tumour Site

Presenters

Andre Freitas

Authors

A. Freitas

Author affiliations

  • Cancer Biomarker Centre, Cancer Research UK Manchester Institute - The University of Manchester, SK10 4TG - Macclesfield/GB

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.